Analyst consensus rating
Lipocine Analyst Rating: none
Direct answer
Lipocine's consensus rating is none.
2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $5.00.
Forecast evidence checked October 19, 2026.
Get free Lipocine email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.56
- Average price target
- $5.00
- High price target
- $6.00
- Low price target
- $4.00
- Low target gap
- +156.4%
- Target upside
- +220.5%
- High target gap
- +284.6%
- Target range width
- 128.2%
- Consensus rating
- none
- Analysts
- 2
- Evidence date
- October 19, 2026
- Valid through
- October 26, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Lipocine?
Lipocine has a verified none consensus. The same dataset has an average price target of $5.00.
How far are Lipocine's low and high targets from the recorded price?
The low target implies +156.4%, while the high target implies +284.6%.
How many analysts are included in Lipocine's consensus?
The verified consensus includes 2 analysts.
How is Lipocine's target upside or downside calculated?
The average target of $5.00 is divided by the recorded price of $1.56, then one is subtracted to produce +220.5%. This does not guarantee a future return.
When was Lipocine's analyst forecast verified?
The data was verified on 2026-10-19. The dataset is valid through 2026-10-26.